{"name":"Adare Pharmaceuticals, Inc.","slug":"adare-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"APT-1011","genericName":"APT-1011","slug":"apt-1011","indication":"Oral delivery enhancement for peptide and protein drugs in phase 3 development","status":"phase_3"}]}],"pipeline":[{"name":"APT-1011","genericName":"APT-1011","slug":"apt-1011","phase":"phase_3","mechanism":"APT-1011 is a permeation enhancer designed to improve the oral bioavailability of poorly absorbed drugs by modulating intestinal tight junctions.","indications":["Oral delivery enhancement for peptide and protein drugs in phase 3 development"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPdzFrOHBEeWc1Q3dJaFUza2JscUc0SkVNSFRXOExGWUNxUUFoNnpYTlo3RklyZjY4LTF2QnlQOGxWV3NIamhwbmdsSHJ3RmdXWDBXYnQ3RXhyT1RLS05GMG1tMTVtSjB1MkZGeDhEUVRhblFXNmxDSk55dmJKU3JTdkVNQlRvaU9UaVRtN0VxOFhNcDNjTHRmcjAzOGZaWGZQU1NLcUlZZ3hHZ3hCRlh2TlNubG85QQ?oc=5","date":"2025-12-25","type":"pipeline","source":"PennLive.com","summary":"Pa. company to close manufacturing facility; 137 people to be laid off - PennLive.com","headline":"Pa. company to close manufacturing facility; 137 people to be laid off","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOUEhMM1lqc0ktTDQ3aUdfUWpKMzI2b3ZUTkJLYzRGRXAxUTJyeFRLMjR4YzZIRDljdURRYThxSlBDTFhYeUx2NUJidWFKMTlqa2pVUEVFazlPemxiajREa2hxUjFtQ214dEoxa0JvWHdUMTBFTUlpMFVqTHU3N1pCcnVGSUhpby1sN2JSNDNn?oc=5","date":"2025-12-08","type":"pipeline","source":"Strauss Borrelli PLLC","summary":"Adare Pharma Solutions WARN Act Investigation - Strauss Borrelli PLLC","headline":"Adare Pharma Solutions WARN Act Investigation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPbTJ5NmsydXkwcHk2OHNRam00VE9DZmRMQlROTkxCa0lmdnozQkc5WnUxN3luWXlRTUQ2SV9aZ1J1a3BCV2dmYkJrZHFHZnMyVXc3bFhUdmZKVHlHU3Q4SlMzenZhVFJ6WFNGZjBZeW83WmJDVVFYZXd1djZxM1lSeENkZXMtclVLWHlPazdmZnc3ekxMSzd1TDdqbUV2UU1YUUhkYm5mNW9BQQ?oc=5","date":"2025-12-08","type":"pipeline","source":"The Business Journals","summary":"Adare Pharma Solutions to close Philadelphia plant, eliminating 137 jobs - The Business Journals","headline":"Adare Pharma Solutions to close Philadelphia plant, eliminating 137 jobs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9IanZTY0tUNkNGa1ZKazRYM09hNFd4VDZOenJxT0F1SVVzYVhVNy1qNmhtZ0xfa2dtYnVQMWNZUGc5UV9FcjU1QVdHNFZEd1hqZnN1bGMxZHFVV2hIdlRxaUk1WkluZ2lKeGxfSHNn?oc=5","date":"2025-01-16","type":"pipeline","source":"Northeast Times","summary":"Adare Pharma Relocates to Philly with $16.8M Expansion - Northeast Times","headline":"Adare Pharma Relocates to Philly with $16.8M Expansion","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-10-07","type":"pipeline","source":"WHIO TV","summary":"‘Catastrophic failure’ of equipment causes explosion, fire at pharmaceutical business - WHIO TV","headline":"‘Catastrophic failure’ of equipment causes explosion, fire at pharmaceutical business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQZzE4R1l4X0R0X1dWYjd5cW1kbndMdExMWnlQZWZLNDgtQTlCSGNRM1FXdTBKamhGWUZBd0tZbzJBWXExMnBhc0JqSUpDZzdocjMzblc3RFhhSUM2YkR4NGdGejNyeWJvQkNaWkFLNnhYWmNaa0tSVXFMZzBwN2JNU0R5YnlLcVpJU3ZqMzFYSXJjcFFnX05fdG15em1Ic0wzV0dsUERFb29ZUlRMUHYtbjRFNA?oc=5","date":"2024-09-18","type":"deal","source":"Contract Pharma","summary":"Adare Pharma, Laxxon Partner to Advance 3D Printed Oral Dosage Forms - Contract Pharma","headline":"Adare Pharma, Laxxon Partner to Advance 3D Printed Oral Dosage Forms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPRVV3NUR6TzJnUHVJRU5XYWFQdFM3N2R1Z3pDUmVjQmZqUVBOSlZqdkNseTlsbThMY0lORFBEVzFsSzNYTl9TcVJGQUstZkhIVTFuZGUxSXRwVTBFQUs0dVdCZVBQRXd3dUdiemdsb2ZlQTFDakFVYWxFNHo1SC1EVUh6NG5DWFgwRnRCM052MFE5OHFDV1g5MkphNWd6cXNtM2lEVHZEYTZOcUduZEIzNEdITFdibThxeXdj?oc=5","date":"2024-09-17","type":"pipeline","source":"Contract Pharma","summary":"Adare Pharma Solutions Invests $16.8M to Relocate HQ and Upgrade Facilities - Contract Pharma","headline":"Adare Pharma Solutions Invests $16.8M to Relocate HQ and Upgrade Facilities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxORFlXQnZyVFhKNDByalZBREJFNm9JOVNHdDQ3ajA5aENjd3VZcmt4TWZmTURCSHZWNmNwN2xPQ1B4QnJuMkNxdHZUcURlM21BdzVsV3lsRnctelBxSEoyN0U0d1RYWnpnMEVRQWE2SXh5UkZ6VVBnZEg5amZqZEhHYjZxQ1FacDBPWG9QdWkxQ3c3TThWckhOME1ETHhkTVFUcmNPbHpFNy12Y1k1TFVUNQ?oc=5","date":"2024-08-01","type":"pipeline","source":"The Business Journals","summary":"Adare Pharma moving HQ to Northeast Philadelphia from New Jersey - The Business Journals","headline":"Adare Pharma moving HQ to Northeast Philadelphia from New Jersey","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQYUpUaUl3LXo1bkNPdkZRSGZGTTVwclNITFlNS1JmTXhoV1lnSVV6N3cwQldYMmZsakVKSUdGN2JiWXhteUFXemRvRVRnT0Z5RkV2aXQxaXZDTGR3TWJsekhPa0NSVFNCd3BvOVNITmtrbkF6MUdsTWZNMXo1RDFxRUNXRFlwM3FTZnN3bEJtb25qWVUxSnZJRzJWX1A?oc=5","date":"2024-05-01","type":"pipeline","source":"PharmTech.com","summary":"Adare Expands High Potency Handling Capabilities in US and Europe - PharmTech.com","headline":"Adare Expands High Potency Handling Capabilities in US and Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNMXZid1dHd0tmU2k5bFA3YVU0VGRXbUFIOVRGZ2RLQ2MtOHpHSkVqYjB3LV8yRkF2Z1hmdVdnT3lfaHNGbkNrSENVck9WZi1XbzZwNXB4dUFkVkRsanhCdVhRb0YwbGRTZHBLLWZxSDhKZGsxT2txWURaWkZqMlJqYko1akplRlhnSUkyc0k5eUdOT2FmY1FqdjhaVnVCdTFJeDhfcUw2Y0ZXZkZsck5wUkdaTm1ESk41bDdTX1V3YmJPb0tYZENOeXNQcmhLd3pSSnJHQQ?oc=5","date":"2021-12-01","type":"deal","source":"PR Newswire","summary":"Adare Pharma Solutions Acquires Frontida BioPharm to Expand Leading CDMO Offerings - PR Newswire","headline":"Adare Pharma Solutions Acquires Frontida BioPharm to Expand Leading CDMO Offerings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOMzdjRkx0MDFrY3dEX3NYcUlaTDJzd205VXNQZHJJQ0ZKOUF6LTUxUEpUbjJqdGswVzhNTUJ3SjhmM1M0OGI0Y0JWNDRlZEVRZ2FCazkwVGI1Wi1ua0d4LXdRUHJ5WjVlaEUtUjA0c3hmNUg5V2JSU0VfeTlMd0Z0SHNIclhuMDFJNGhMZ2hhamtxT1BLbWpMTkc1X3pfQ0RBWkxJckxBY1FHWEFQalRBeHZLR0FMMk1mZlE?oc=5","date":"2020-09-23","type":"pipeline","source":"ROI-NJ","summary":"Lawrenceville contract manufacturing business sold to 2 private equity firms - ROI-NJ","headline":"Lawrenceville contract manufacturing business sold to 2 private equity firms - ROI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ0MzTzlDYW1la0hIZkVJUHBqNG8yWDJpelZZRkFkd1FJeTZTaWdpVlFaNDRDdm1KUHIwYncyb0N3SnlzT1FTN3B5emRRbDA4WTZ0aGhKZlgxOWVaRElsWWN0QV9EUGVYLWJiS3FXbGlxY2tEQ1M1RGR5OHZpNnU4YW8wMVpuZTVoX2JSZjNsVTJsRUI4bW9lNWJpZ2RyRkpz?oc=5","date":"2015-04-02","type":"pipeline","source":"tpg.com","summary":"TPG Completes Acquisition of Aptalis Pharmaceutical Technologies, Company Renamed Adare Pharmaceuticals - tpg.com","headline":"TPG Completes Acquisition of Aptalis Pharmaceutical Technologies, Company Renamed Adare Pharmaceuticals","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}